Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Japan’s 30-Year Government Bond Yield Surpasses 3%, Hitting Nearly Two-Month High

Japan’s 30-Year Government Bond Yield Surpasses 3%, Hitting Nearly Two-Month High

ChaincatcherChaincatcher2025/07/08 13:19
Show original

According to ChainCatcher, citing CoinDesk, Japan's 30-year government bond yield has surged more than 30 basis points over the past three days, breaking through the 3% mark and reaching its highest level since May 23. The 40-year yield also climbed 15 basis points to 3.36%. Market analysts believe the rising yields reflect investor concerns over fiscal policy ahead of Japan's House of Councillors election.

Analysts point out that the correlation between US and Japanese bond yields could intensify global interest rate volatility, potentially putting pressure on risk assets including Bitcoin. The results of the 20-year government bond auction by Japan's Ministry of Finance this Thursday are drawing significant attention.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.

智通财经2026/09/14 01:06
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas